Showing 2241-2250 of 3223 results for "".
- For 2019, ADA and ACC Align Their Diabetes Recommendationshttps://modernod.com/news/for-2019-ada-and-acc-align-their-diabetes-recommendations/2476250/For the first time in its annual diabetes management guidelines, the American Diabetes Association (ADA) has aligned its recommendations with those of the American College of Cardiology (ACC) for cardiovascular risk reduction in people with type 2 diabetes, according to a report in Medscape.
- Alcon Introduces New Medical Affairs Website in North America, Expanding Support for Patient Care and Clinical Communityhttps://modernod.com/news/alcon-introduces-new-medical-affairs-website-in-north-america-expanding-support-for-patient-care-and-clinical-community/2476149/Alcon recently launched a new website, AlconScience.com, for US- and Canada-based eye care professionals and academic institutions. The new medical affairs website consolidates information about Alcon’s scientific, academic, and related activities into one portal. Visitors may download clinically
- Study: Ocular Technology Provides Early Detection of Alzheimer’s Diseasehttps://modernod.com/news/study-ocular-technology-provides-early-detection-of-alzheimers-disease/2479626/A recent study from JAMA Ophthalmology finds that a specific type of noninvasive eye testing procedure may help assess risk for Alzheimer’s disease. One in 10 Americans over the age 65 has Alzheimer’s, while one-third over the age of 85 have the disease. Fortunately, res
- Alcon’s Phaco Development (PD) Program Celebrates 10 Yearshttps://modernod.com/news/alcons-phaco-development-pd-program-celebrates-10-years/2476164/The Phaco Development (PD) program, an initiative between Alcon and specialist training institutes that builds cataract surgical capabilities across Asia and Russia, is celebrating its 10th anniversary this year. Over th
- Alcon Launches Alcon Retina Fellows Institute to Support Future Leaders of Ophthalmologyhttps://modernod.com/news/alcon-launches-alcon-retina-fellows-institute-to-support-future-leaders-of-ophthalmology/2479630/Alcon announced it is expanding its support of eye care professionals through the launch of a one-of-a-kind training opportunity, the Alcon Retina Fellows Institute. The unique educational offering supports retina fellows during a weekend-long training at the Alcon Experience Center in Fort Worth
- Alcon Outlines Growth Strategy as Spinoff Nearshttps://modernod.com/news/alcon-outlines-growth-strategy-as-spinoff-nears/2479633/With its proposed spinoff from Novartis just months away, Alcon executives said they will focus on an aging population and the myopia epidemic to drive growth. Alcon executives
- Verily, Alcon, Halt Project to Create a Glucose-Measuring Contact Lens; Other Eye-Monitoring Projects Continuehttps://modernod.com/news/verily-alcon-halt-work-on-glucose-sensing-smart-contact-lens/2479656/Google’s life sciences company Verily and Alcon have decided to halt their work on a smart contact lens to measure glucose levels in users with diabetes. In a blog post, Verily chief technical o
- U.S. Appeals Court Rules Against Allergan Over Validity of Restasis Patentshttps://modernod.com/news/u-s-appeals-court-rules-against-allergan-over-validity-of-restasis-patents/2479660/Allergan’s patents on its blockbuster eye drug Restasis are invalid, a U.S. appeals court ruled, according to a Bloomberg report. Without issuing a formal opinion, the U.
- Prevent Blindness Elects Three New Members to National Board of Directorshttps://modernod.com/news/prevent-blindness-elects-three-new-members-to-national-board-of-directors-2/2479700/Prevent Blindness has announced that Paul Delatore, Global Head, Market Access at Alcon; Jim McGrann, Chairman & CEO of Healthy Eyes Advantage; and Rajeev S. Ramchandran, MD, Associate Professor of Ophthalmology in the University of Rochester Medical School’s Department of Ophthalmology, have
- Evidence Mounts That an Eye Scan May Detect Early Alzheimer’s Diseasehttps://modernod.com/news/evidence-mounts-that-an-eye-scan-may-detect-early-alzheimers-disease/2479725/Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer’s disease in a matter of seconds. The researchers show that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer’s. Even patients who have a family histo